These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27206913)

  • 1. Bioresorbable Scaffold With Drug-Coated Balloon: A "Biodegradable" Model for Bifurcation Lesions Treatment. The New Intriguing Chapter of the "Leaving Nothing Behind" Saga.
    Buccheri D; Piraino D; Andolina G
    Am J Cardiol; 2016 Jul; 118(2):308-9. PubMed ID: 27206913
    [No Abstract]   [Full Text] [Related]  

  • 2. No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.
    Naganuma T; Latib A; Ielasi A; Panoulas VF; Sato K; Miyazaki T; Colombo A
    Int J Cardiol; 2014 Apr; 172(3):618-9. PubMed ID: 24495653
    [No Abstract]   [Full Text] [Related]  

  • 3. Percutaneous coronary intervention: balloons, stents and scaffolds.
    Colleran R; Kastrati A
    Clin Res Cardiol; 2018 Aug; 107(Suppl 2):55-63. PubMed ID: 30039189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design Principles of Bioresorbable Polymeric Scaffolds.
    Kossuth MB; Perkins LEL; Rapoza RJ
    Interv Cardiol Clin; 2016 Jul; 5(3):349-355. PubMed ID: 28582032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioresorbable scaffolding after drug-coated balloons: a new chapter of the "leave nothing behind" saga.
    Cortese B; Sebik R; Seregni R; Silva PL
    Int J Cardiol; 2014 May; 173(3):e67-9. PubMed ID: 24704408
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of coronary bifurcation lesions: current knowledge and future perspectives.
    Elwany M; Palma GD; Cortese B
    Future Cardiol; 2018 Mar; 14(2):165-179. PubMed ID: 29372810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".
    Cortés C; Jaguszewski M; Schincariol M; Durán-Cortés MA; Limon U; Gutiérrez-Chico JL
    Cardiol J; 2017; 24(6):700-701. PubMed ID: 29297580
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioresorbable Vascular Scaffolds in Coronary Bifurcation Lesions: Only in Expert Hands.
    Colleran R; Byrne RA
    Rev Esp Cardiol (Engl Ed); 2016 Jun; 69(6):543-6. PubMed ID: 27157886
    [No Abstract]   [Full Text] [Related]  

  • 10. First ad hoc bioresorbable vascular scaffold bench test: a glimpse into percutaneous bifurcation interventions.
    Sgueglia GA; D'Errico F; Gioffrè G; De Santis A; Gaspardone A
    Int J Cardiol; 2014 Apr; 172(3):604-6. PubMed ID: 24491860
    [No Abstract]   [Full Text] [Related]  

  • 11. The EuroIntervention coronary bifurcation treatment supplement.
    Stankovic G; Lassen JF; Hildick-Smith D; Lefèvre T; Louvard Y; Gwon HC; Grundeken MJ
    EuroIntervention; 2015; 11 Suppl V():V9-11. PubMed ID: 25983181
    [No Abstract]   [Full Text] [Related]  

  • 12. Paving the way to a bioresorbable technology: Development of the absorb BRS program.
    Perkins LE; Kossuth MB; Fox JC; Rapoza RJ
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):1-9. PubMed ID: 27797462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioresorbable vascular scaffolds: From patient selection to optimal scaffold implantation; tips and tricks to minimize device failure.
    Tanaka A; Jabbour RJ; Latib A; Colombo A
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):10-20. PubMed ID: 27797460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioresorbable Scaffolds: Clinical Outcomes and Considerations.
    Capodanno D
    Interv Cardiol Clin; 2016 Jul; 5(3):357-363. PubMed ID: 28582033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioresorbable vascular scaffolds for left main lesions; a novel strategy to overcome limitations.
    Miyazaki T; Panoulas VF; Sato K; Naganuma T; Latib A; Colombo A
    Int J Cardiol; 2014 Jul; 175(1):e11-3. PubMed ID: 24845788
    [No Abstract]   [Full Text] [Related]  

  • 16. Computed tomography angiography for guiding and follow-up of magnesium-bioresorbable scaffold implantation.
    Opolski MP; Kepka C; Wojakowski W; Witkowski A
    Clin Res Cardiol; 2019 Mar; 108(3):344-346. PubMed ID: 30182164
    [No Abstract]   [Full Text] [Related]  

  • 17. Proximal optimization technique and kissing balloon inflations with the bioresorbable vascular scaffold for coronary bifurcation percutaneous coronary intervention.
    McGeoch RJ; Tanaka K; Overgaard CB; Bezerra HG; Džavík V
    Can J Cardiol; 2014 Nov; 30(11):1461.e5-7. PubMed ID: 25442451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioresorbable vascular scaffolds for the treatment of coronary artery disease: Clinical outcomes from randomized controlled trials.
    Rizik DG; Hermiller JB; Kereiakes DJ
    Catheter Cardiovasc Interv; 2016 Nov; 88(S1):21-30. PubMed ID: 27797464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up evaluation of unapposed bioresorbable vascular scaffold at a coronary bifurcation using optical coherence tomography.
    Danson E; Bhindi R; Hansen P
    Int J Cardiol; 2014 Dec; 177(2):e84-6. PubMed ID: 25456696
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of bioresorbable scaffolds: hype or hope?
    Tan HC; Ananthakrishna R
    Singapore Med J; 2017 Sep; 58(9):512-515. PubMed ID: 27868135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.